Royal Sense Limited (BOM:544143)

Market Cap	1.11B
Revenue (ttm)	617.34M
Net Income (ttm)	63.31M
Shares Out	5.35M
EPS (ttm)	11.83
PE Ratio	17.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	2,500
Open	210.00
Previous Close	210.00
Day's Range	210.00 - 210.00
52-Week Range	133.00 - 316.05
Beta	n/a
RSI	35.49
Earnings Date	Aug 8, 2025

About Akoya Biosciences

Royal Sense Limited engages in supplying various surgical accessories, tools, equipment, and other pharmaceuticals products for hospitals, laboratories, institutions, and clinics under the STERGIC brand name. It offers medical equipment, surgical instruments and consumables, laboratory equipment and reagents, medical consumables, diagnostics equipment, sanitary napkins, pharmaceuticals, medicine, and cosmetics, as well as disposable medical supplies and diagnostic kits. The company serves Ministry of Health through distributors and sub-distribu...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2015
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544143

Financial Performance

In 2024, Royal Sense's revenue was 617.34 million, an increase of 246.82% compared to the previous year's 178.00 million. Earnings were 63.31 million, an increase of 298.46%.